Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON39883Withdrawn
Open-label trial of Rabies vaccine in rabies (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Protective rabies virus neutralizing antibody response. Planned start Mar 2013; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON39883.